ADMA - ADMA Biologics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADMA is currently covered by 4 analysts with an average price target of $19. This is a potential upside of $9.28 (95.47%) from yesterday's end of day stock price of $9.72.

ADMA Biologics's activity chart (see below) currently has 84 price targets and 73 ratings on display. The stock rating distribution of ADMA is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 76.25% with an average time for these price targets to be met of 851.07 days.

Highest price target for ADMA is $21, Lowest price target is $17, average price target is $19.

Most recent stock forecast was given by ANTHONY PETRONE from MIZUHO on 15-Jul-2026. First documented stock forecast 09-Sep-2015.

Currently out of the existing stock ratings of ADMA, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Jun-2019

$17

$7.28 (74.90%)

$20

2 months 20 days ago
(15-Jul-2026)

11/16 (68.75%)

$8.32 (95.85%)

570

Buy Since 10-May-2024

$21

$11.28 (116.05%)

$10

3 months 17 days ago
(18-Jun-2026)

1/2 (50%)

$12.69 (152.71%)

25

Buy Since 21-Apr-2026

$18

$8.28 (85.19%)

$21

4 months 28 days ago
(07-May-2026)

1/3 (33.33%)

$9.53 (112.51%)

209

Hold Since 12-Apr-2026

5 months 23 days ago
(12-Apr-2026)

9/10 (90%)

$7.99 (46.97%)

126

Buy Since 12-Oct-2018

$32

$22.28 (229.22%)

$25

1 years 4 months 27 days ago
(08-May-2025)

6/8 (75%)

$10.8 (50.94%)

1093

Show more analysts

Please expand the browser size to see the chart

What is ADMA (ADMA Biologics) average time for price targets to be met?

On average it took 851 days for the stock forecasts to be reached, with an average price target met ratio of 76.25%.

Which analyst most recently updated their price target on ADMA (ADMA Biologics)?

Anthony Petrone

Which analyst has the most public recommendations on ADMA (ADMA Biologics)?

Anthony Petrone works at MIZUHO and has 3 price targets and 1 ratings on ADMA

Which analyst is the currently most bullish on ADMA (ADMA Biologics)?

Elliot Wilbur with the highest potential upside of $22.28

Which analyst is the currently most reserved on ADMA (ADMA Biologics)?

Leland Gershell with the lowest potential downside of -$5.72
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?